Regarding the matter of the island laboratory, the U.S. Special Envoy agreed almost immediately. Although building an international top-tier biomedical research lab in a place like the Maldives comes with a costly price tag, for the pharmaceutical conglomerate backing him, it's practically insignificant.
The annual expenditures of pharmaceutical companies worldwide on new drug development are always calculated in units of billions of U.S. dollars. If a company doesn't burn through a few billion dollars in a year on research, its efforts in new drug development are considered subpar.
Thus, while constructing an international top-tier biomedical research lab is expensive, it's barely worth mentioning to these pharmaceutical giants. They simply treat it as yet another failed drug development project. Besides, they could exchange for the patent of the broad-spectrum anti-cancer drug from Chen Yu, which is truly the money-making gem.
